Advanced Search

All Active Funding Opportunities

For questions regarding these opportunities, please contact Sarah Laye at: slaye@som.umaryland.edu.

Date Posted Organization Title Website Type LOI and/or Application Due Date Comments / Documents
12/05/22 NIH Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics Link NIH NOSI Application due: 01/08/26
12/05/22 NCI Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) Link NIH Application due: 10/23/24 LOI due 30 days before application due date
12/05/22 NCI Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) Link NIH Application due: 06/14/24 LOI due 30 days before application due date
12/05/22 NIH The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
11/04/22 UMB SOM Office of Research Career Development Funding for Research on COVID-19 and Information for NIH Applicants re: Impact of COVID-19 on Grants and Submissions Link COVID Funding for Research on COVID-19 and Information for NIH Applicants re: Impact of COVID-19 on Grants and Submissions265.06 KB
11/04/22 UMSOM Large Grant Acceleration Program (LGAP) Link Internal LGAP flyer2.54 MB
11/04/22 UM VENTURES UMCP / UMB Coronavirus Medical Device Challenge Program COVID Applications will be accepted on a rolling basis through May 2020 (or until funds are exhausted); funding decisions will be made bi-weekly until all funds are spent. Coronavirus Medical Device Challenge Program Guidelines and Instructions FY202069.49 KB
11/04/22 NIH Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection Link COVID Expiration Date: 9/8/24.
11/04/22 US Department of Veteran Affairs (VA) VA opportunities Link Internal Deadline varies by grant

If interested in obtaining the PDF version of a particular VA opportunity and to inquire on eligibility, please email Natalie Dugger (Natalie.Dugger@va.gov) and cc Sarah Laye (slaye@som.umaryland.edu) on your request. Note that VA opportunities are specific and you must confirm eligibility with the VA.
11/04/22 University of Maryland Baltimore, Institute for Clinical & Translational Research (UMB ICTR) Special Call for COVID-19 ICTR Voucher Applications Link COVID Applications will be accepted on a rolling basis.
10/28/22 NIH Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers Link NOSI Application due: 07/02/25 Expiration Date: 7/2/25
10/28/22 Cancer Research Institute CRI Grants (various) Link Foundation Deadline varies by grant
10/21/22 NCI, NHGRI, NIDCR Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
10/21/22 Pfizer 2023 Pfizer’s Competitive Grants Program (various) Link Industry Deadline varies by grant
10/21/22 NIH National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Link NIH Standard due dates apply LOI required and due 30 days prior to the application due date.
10/21/22 Mesothelioma Applied Research Foundation 2022 Mesothelioma Research Grant Link Foundation LOI due: 11/21/2022
10/21/22 NIH Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology Link NIH NOSI Application due: 01/08/26
10/21/22 NCI Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, 2023 (P50 Clinical Trial Required) Link NIH Standard due dates apply
10/21/22 NCI Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
10/14/22 NCI Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) Link NIH LOI due: 11/28/2022
10/14/22 NCI Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
10/14/22 NCI Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
10/14/22 NCI Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas Link NOSI Expiration Date: 5/8/23
10/07/22 NIH Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer Link NOSI Expiration Date: 5/8/27
10/07/22 NIH Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project Link NOSI Expiration Date: 5/1/25
10/07/22 NIH Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy Link NOSI Expiration Date: 7/5/24.
10/07/22 NCI Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
10/07/22 NIH Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments Link NOSI Expiration Date: 5/8/24
09/23/22 Melanoma Research Foundation (MRF) Melanoma Research Foundation Research Grant RFPs (various) Link Foundation Due date varies by grant
09/22/22 NIH Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) Link NOSI Expiration Date: 2/1/23
09/22/22 NIH Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional) Link NOSI Expiration Date: 3/17/25
09/22/22 NIH Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech Link NOSI Expiration Date: 6/21/24
09/22/22 American Association for Cancer Research (AACR) AACR AWARD FOR OUTSTANDING ACHIEVEMENT IN BLOOD CANCER RESEARCH Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) AACR JAMES S. EWING-THELMA B. DUNN AWARD FOR OUTSTANDING ACHIEVEMENT IN PATHOLOGY IN CANCER RESEARCH Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) AACR Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research Link Award Nomination Deadline: 9/30/22
09/22/22 American Association for Cancer Research (AACR) AACR-Women in Cancer Research Charlotte Friend Lectureship Link Lectureship Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) AACR-Minorities in Cancer Research Jane Cooke Wright Memorial Lectureship Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) AACR Team Science Award Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research AACR Award for Lifetime Achievement in Cancer Research Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research & ST. BALDRICK’S FOUNDATION AACR-ST. BALDRICK’S FOUNDATION AWARD FOR OUTSTANDING ACHIEVEMENT IN PEDIATRIC CANCER RESEARCH Link Award LOI due: 09/15/2024
09/22/22 American Association for Cancer Research (AACR) AACR Award for Outstanding Achievement in Chemistry in Cancer Research Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research AACR AWARD FOR OUTSTANDING ACHIEVEMENT IN BASIC CANCER RESEARCH Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) & Eli Lilly and Company AACR-G.H.A. CLOWES AWARD FOR OUTSTANDING BASIC CANCER RESEARCH Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) & Bristol-Myers Squibb AACR-JOSEPH H. BURCHENAL AWARD FOR OUTSTANDING ACHIEVEMENT IN CLINICAL CANCER RESEARCH Link Award Application due: 09/15/24
09/22/22 American Association for Cancer Research (AACR) & The Princess Takamatsu Cancer Research Fund (Japan AACR PRINCESS TAKAMATSU MEMORIAL LECTURESHIP Link Lectureship Application due: 09/15/24
09/22/22 Breast Cancer Alliance Breast Cancer Alliance grants (various) Link Foundation LOI/application deadline varies by grant
09/15/22 NCI Notice of Special Interest: Administrative Supplements to Participate in the NCI Early-stage Surgeon Scientist Program (ESSP) Link NOSI Expiration Date: 12/9/23
09/15/22 NCI Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) Link NIH Application due: 07/01/24 LOI due 30 days before application due date
09/15/22 NCI The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) Link NIH Application due: 06/20/24 LOI due 30 days before application due date
08/19/22 EMDR Foundation EMDR Research Consultation Awards Link Foundation Applications will be accepted year round, and applicants will be notified of fu… Applications accepted year round
08/19/22 Rita Allen Foundation Rita Allen Foundation Scholars Program Link Foundation
08/19/22 NIH Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) Link NIH Application due: 06/10/24
08/19/22 NIH Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) Link NIH Standard due dates apply
08/16/22 NCI Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Link NIH Application due: 07/29/24
08/16/22 NCI Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) Link NIH Application due: 07/29/24
08/04/22 NCI National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) Link NIH Standard due dates apply LOI required and due 30 days prior to the application due date.
08/04/22 NIH Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Link NIH Standard due dates apply
08/04/22 NCI Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Link NIH Standard due dates apply Next application deadline is 2/5/2023, LOI due 1/5/2023.
08/04/22 NIH Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
08/04/22 Foundation for Women’s Cancer (FWC) 2022-2023 Foundation for Women's Cancer Research Grants & Prizes (various) Link Foundation Due dates vary by grant For research grants, abstracts are due 9/6/22. For awards and prizes, applications are due 11/18/22.
08/04/22 NCI Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Link NIH Standard due dates apply Earliest due date for new applications is 10/5/22. LOI not required.
08/04/22 NIH Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI required and due 30 days prior to the application due date.
08/02/22 NIH Notice of Special Interest (NOSI): Promoting Mechanistic Research on Therapeutic and Other Biological Properties of Minor Cannabinoids and Terpenes Link NIH NOSI Application due: 07/01/25 Expiration Date: 7/1/25
08/02/22 NCI Biology of Bladder Cancer (R21 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 9/16/22 for next application due date of 10/16/22.
08/02/22 NCI NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Link NIH Standard due dates apply
08/02/22 NCI NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) Link NIH Standard due dates apply
08/02/22 NCI The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
08/02/22 NIH Co-infection and Cancer (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply LOI required and due 30 days prior to the application due date.
08/02/22 Rivkin Center Rivkin Center Scientific Grants (various) Link Foundation Due dates vary by grant
08/02/22 NIH Notice of Special Interest: Epidemiology and Prevention in Alcohol Research Link NIH NOSI Application due: 09/06/26
08/02/22 NCI Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) Link NIH Application due: 06/07/24 LOI due 30 days before application due date
08/02/22 NCI Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
08/02/22 NCI Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
08/02/22 NCI NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) Link NIH Standard due dates apply
08/02/22 NCI Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
08/02/22 NCI Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) Link NIH Application due: 06/11/24 LOI due 30 days before application due date